Aspire BioPharma, Inc.

10-Year Study

ASBP.US · Healthcare · US · Common Stock

Executive Summary: Aspire BioPharma, Inc. has compounded at -84.6% annually over the last 10 years, with a maximum drawdown of 100.0% and an annualized volatility of 702.0%.

1Y CAGR
-99.1%
3Y CAGR
-92.4%
5Y CAGR
-84.6%
10Y CAGR
-84.6%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
100.0%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
-0.56
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
-0.55
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
107.4%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2023 · +5.7%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · -98.9%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
50%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-59.7-34.7-25.9-78.4————————-95.8%
202512.5-88.4-61.1-27.31.4-37.441.650.9-64.285.9-72.324.5-98.9%
20240.21.0-0.01.20.90.2-0.2-0.28.7-6.30.50.05.6%
20231.00.30.70.1-1.10.20.83.4-0.20.30.00.35.7%
2022————-0.30.30.50.60.50.30.80.53.2%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 702.0%. The dominant macroeconomic risk driver is SHV.US, accounting for 92.4% of variance. Idiosyncratic stock-specific factors contribute 2.6%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2022-04-0110000
2022-05-019969.939574891374
2022-06-0110000
2022-07-0110045.089873194574
2022-08-0110105.209958943462
2022-09-0110160.320483486488
2022-10-0110190.38014412675
2022-11-0110270.540768104178
2022-12-0110320.640966972978
2023-01-0110420.84136471058
2023-02-0110450.901789819207
2023-03-0110521.041762448182
2023-04-0110536.071975002496
2023-05-0110420.84136471058
2023-06-0110440.881138470755
2023-07-0110521.041762448182
2023-08-0110876.753480204015
2023-09-0110851.703380769615
2023-10-0110881.763041409875
2023-11-0110881.763041409875
2023-12-0110911.823466518503
2024-01-0110931.863240278677
2024-02-0111042.083524896365
2024-03-0111037.073963690505
2024-04-0111172.344347742594
2024-05-0111272.544745480196
2024-06-0111292.58451924037
2024-07-0111272.544745480196
2024-08-0111252.504971720022
2024-09-0112234.4684108675
2024-10-0111462.92565407531
2024-11-0111518.035414149974
2024-12-0111523.0457398242
2025-01-0112965.930855670971
2025-02-011503.005966064026
2025-03-01584.1683111655344
2025-04-01424.8496634733804
2025-05-01430.8617293833966
2025-06-01269.53907564766143
2025-07-01381.7635096467499
2025-08-01576.15228699121
2025-09-01206.41281360594684
2025-10-01383.767515690331
2025-11-01106.2124158683451
2025-12-01132.2645302693543
2026-01-0153.3567146620293
2026-02-0134.8196382138166
2026-03-0125.80160241743245
2026-04-015.571142114210656
Annual Return Matrix
YearAnnual Return
20230.05728156821241659
20240.05601467758172163
2025-0.9885217386743297
2026-0.9578787895525344
Total Factor Risk
7.020468182301609
VTI.US Exposure
0.031405460796047696
VEA.US Exposure
0.0008644495165906934
VWO.US Exposure
0.0005349901162917738
QQQ.US Exposure
0.0006284373186149274
VTV.US Exposure
0.0015122910505821919
IJR.US Exposure
0.0002544813804859541
QUAL.US Exposure
0.0005603006148260971
SHV.US Exposure
0.9237548749397266
TLT.US Exposure
0.0012238635689452518
LQD.US Exposure
0.007390009950046646
HYG.US Exposure
0.00038807591272825435
GLD.US Exposure
0.00030241377112939766
USO.US Exposure
0.0003660201532457417
VNQ.US Exposure
0.0009520117874549079
BTC-USD.CC Exposure
0.0002900835201815774
CPER.US Exposure
0.000026104740025052118
VIX.INDX Exposure
0.0017342999968567182
UUP.US Exposure
0.00005217820799432091
TIP.US Exposure
0.0016884119280181013
Idiosyncratic Exposure
0.026071240730208063
Value Score
50
Growth Score
50
Profit Score
12.5
Health Score
0
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
702.0%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Forward P/EForward P/E RatioA valuation metric that compares the current stock price to estimated future earnings per share.Click for full definition →No estimate availableN/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Squeeze RiskShort Squeeze RiskA situation where a sharp rise in the price of a stock forces short sellers to buy shares to cover their positions, further driving up the price.Click for full definition →Extreme
Market Cap$1.4M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
1.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
-0.47
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators: distance from 50/200-Day SMA, 52-Week High proximity, Golden Cross trend signal, RSI momentum gauge, Fibonacci retracement levels, and Beta (market sensitivity).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-79.2%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-97.3%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
99.2% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.00
Market sensitivity coefficient
Trend SignalGolden Cross & Death CrossTechnical chart patterns that occur when a short-term moving average crosses over a long-term moving average.Click for full definition →
✦ Death Cross
Bearish — 50 SMA below 200 SMA
RSI (14-Day)Relative Strength Index (RSI)A momentum oscillator that measures the speed and change of price movements to identify overbought or oversold conditions.Click for full definition →
26
OversoldNeutralOverbought
Oversold
Fibonacci LevelsFibonacci RetracementTechnical levels based on mathematical ratios that indicate potential support and resistance areas.Click for full definition →
38.2% retracement-98.7%
50.0% retracement-98.4%
61.8% retracement-98.0%
% distance of current price from each 52-week Fibonacci support level.

Frequently Asked Questions & Methodology

Is Aspire BioPharma, Inc. a high-risk investment?

Aspire BioPharma, Inc. (ASBP.US) has an annualized volatility of 702.0% and experienced a maximum drawdown of 100.0% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of ASBP.US?

Over the past 10 years, ASBP.US has generated a Compound Annual Growth Rate (CAGR) of -84.6%. It has had a positive return in 50% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Aspire BioPharma, Inc.

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest